$PFE -8%

#Pfizer dropped sharply after disappointing results for its breast cancer drug.;  study is now halted.

Our analysis shows PFE likely dropping near $34 in coming weeks. However, the technical patterns are positive. We see that as a buying opportunity.

charts: askSlim https://t.co/8xe5rR1NLn